Association of Clinicopathologic and Molecular Tumor Features With Recurrence in Resected Early-Stage Epidermal Growth Factor Receptor–Positive Non–Small Cell Lung Cancer

IMPORTANCE: The recently published ADAURA study has posed a significant dilemma for clinicians in selecting patients for adjuvant osimertinib. Risk factors for recurrence in early-stage epidermal growth factor receptor (EGFR)–positive non–small cell lung cancer (NSCLC) also remain undefined. OBJECTI...

Descripción completa

Detalles Bibliográficos
Autores principales: Saw, Stephanie P. L., Zhou, Siqin, Chen, Jianbin, Lai, Gillianne, Ang, Mei-Kim, Chua, Kevin, Kanesvaran, Ravindran, Ng, Quan Sing, Jain, Amit, Tan, Wan Ling, Rajasekaran, Tanujaa, Lim, Darren W. T., Tan, Aaron, Fong, Kam Weng, Takano, Angela, Cheng, Xin Ming, Lim, Kiat Hon, Koh, Tina, Ong, Boon-Hean, Tan, Eng Huat, Toh, Chee Keong, Skanderup, Anders J., Tan, Sze Huey, Tan, Daniel S. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571655/
https://www.ncbi.nlm.nih.gov/pubmed/34739062
http://dx.doi.org/10.1001/jamanetworkopen.2021.31892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571655/
https://www.ncbi.nlm.nih.gov/pubmed/34739062
http://dx.doi.org/10.1001/jamanetworkopen.2021.31892

Ejemplares similares